Fig. 2From: Levetiracetam may be an unsuitable choice for patients with PRRT2-associated self-limited infantile epilepsyGenetic data of cases with PRRT2 mutations. (A) DNA sequencing chromatograms of seven mutations. (B) conservative analysis of two missense mutationsBack to article page